Macrophage activation syndrome after BNT162b2 mRNA vaccination successfully treated with corticosteroids.

Authors :: Ashizawa N
Takazono T
Umeda M
Yamamoto K
Kawakami A
Mukae H
Source :: Clinical and experimental rheumatology [Clin Exp Rheumatol] 2022 May; Vol. 40 (5), pp. 1060. Date of Electronic Publication: 2022 Jan 05.
Publication Year :: 2022

Subjects :: COVID-19 prevention & control
Humans
Vaccination adverse effects
Adrenal Cortex Hormones therapeutic use
BNT162 Vaccine adverse effects
Macrophage Activation Syndrome chemically induced
Macrophage Activation Syndrome drug therapy

Full Text Access

Tools